Recombinant Human Anti-Insulin precursor Soluble TCR (A4.13) (C-Cys) (CAT#: VS-0622-YF3949)
Human TCR (A4.13) recognizes Insulin precursor peptide (QVELGGGPGAG) in the context of HLA-DQ8. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Specific Inquiry
Specifications
- Host Species
- Human
- Target
- Insulin precursor
- Species Reactivity
- Human
- Epitope
- QVELGGGPGAG
- MHC
- HLA-DQ8
- Clone
- A4.13
- Type
- Soluble TCR (C-Cys)
- Related Disease
- Others
- TCR Expression Strategy
- C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- Hypothetical Protein
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone A4.13"
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF3949. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: Neut, ELISA, FuncS
-2.jpg)
Application: IB, ELISA, FC, FuncS
Application: WB, IHC, ELISA, FC
Application: FC, IHC-Fr, IP, ELISA, Block
Application: ELISA, IHC, FC, IP, IF, Inhib
Application: ELISA, IHC, FC, IP, IF, BL
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, FuncS
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
